Scientific exchange and insights gathering agency focused on healthcare professionals in oncology and hematology. Curio Science, a Vaniam Group company
Joined November 2019
- Tweets6
- Following172
- Followers187
- Likes13
Curio Science retweeted
Our @_CurioScience_ team drives expert-led exchanges with HCPs to gain insights on practice patterns, clinical data, & their impact on decisions across rare diseases. Together, let's advance healthcare and improve outcomes. #RareDiseaseDay
Learn more: loom.ly/vE_QtCg
Curio Science retweeted
Visit our booth #3149 at #ASH2023 to learn more about the @_CurioScience_ team and what they have in store for 2024!
#AnticipatingASH2023
Curio Science retweeted
@maughanonc @neerajaiims @siadaneshmand @DrTFriedlander @_CurioScience_ @AlbigesL @montypal @PBarataMD @OncoAlert @huntsmancancer @kcCURE @EvanHallMD @LisaTachiki @DrChoueiri @Uromigos @DrRanaMcKay @nachoduranm @cdanicas @drenriquegrande @shilpaonc @TiansterZhang @brian_rini – at Salt Lake City, UT
Discussing LITESPARK-005 trial. Some patients getting good responses (22.5% PR, 3.5% CR rates) and durable PFS with #belzutifan in late line, TKI-pretreated pts. @maughanonc @_CurioScience_ #RCC
Curio Science retweeted
We had a GREAT time with 40 other US colleagues to discuss #GI #cancer treatment including Drs. Sugarman @MSKCancerCenter and Ahn @MayoCancerCare + my amazing colleagues @VUMC_Cancer @drlauragoff @KristenCiombor @VUMCDiscoveries 🙏🏻 @_CurioScience_ #alwayslearning #canceresearch
Curio Science retweeted
@_CurioScience_ Opinions in hematologic malignancies: overview of the fields of MM and Lymphoma. It is not surprising that docs feel that #access for Cell therapy is an issue. Evolving field with #Cart #bispecifics . Highlight of the meeting was meeting @szusmani below 👇
Curio Science retweeted
Great heme-malignancy meeting by @_CurioScience_ in Marco Island, FL. Teamwork with longterm friends @SagarLonialMD @szusmani @Dr_AdrianaRossi @myelomatips. Focus on “novel immunotherapies in myeloma”. Fun discussions. Full house!
#mmsm @IMFmyeloma @theMMRF @HealthtreeMM
@DrOlaLandgren covering BCMA directed therapies, highlighting exceptional single agent activity of CARs, BsAbs and also summarizing that Belamaf combos may have a future in RRMM. Cases and Q/A to cover safety/practical considerations coming up soon #mmsm @_CurioScience_ at Opinions in Hematologic Malignancies
